Copyright
©The Author(s) 2020.
World J Cardiol. Jul 26, 2020; 12(7): 342-350
Published online Jul 26, 2020. doi: 10.4330/wjc.v12.i7.342
Published online Jul 26, 2020. doi: 10.4330/wjc.v12.i7.342
Table 3 In-hospital outcomes of propensity matched hepatic cirrhosis patients stratified by presence of atrial fibrillation among 2003-2014
| Non-AF (n = 45504) | AF (n = 45504) | P value | |
| Clinical outcome, n (%) | |||
| In-hospital death | 4697 (10.3) | 5755 (12.6) | < 0.001 |
| Gastrointestinal bleeding | 2329 (5.1) | 1995 (4.4) | < 0.001 |
| Blood transfusion | 10841 (23.8) | 10219 (22.5) | < 0.001 |
| Transient ischemic attack | 124 (0.3) | 134 (0.3) | 0.575 |
| Clinical stroke | 496 (1.1) | 722 (1.6) | < 0.001 |
| Acute kidney injury | 11433 (25.1) | 12810 (28.2) | < 0.001 |
| Discharge status, n (%) | < 0.001 | ||
| Discharged home | 27646 (60.8) | 25705 (56.5) | |
| Discharged SNF/NH/IC | 12242 (26.9) | 13114 (28.8) | |
| Length of stay (mean ± SD, d) | 7 ± 8 | 8 ± 10 | < 0.001 |
| Hospital cost (mean ± SD, $) | 16272 ± 24166 | 20720 ± 33210 | < 0.001 |
- Citation: Darrat YH, Smer A, Elayi CS, Morales GX, Alqahtani F, Alkhouli M, Catanzaro J, Shah J, Salih M. Mortality and morbidity in patients with atrial fibrillation and liver cirrhosis. World J Cardiol 2020; 12(7): 342-350
- URL: https://www.wjgnet.com/1949-8462/full/v12/i7/342.htm
- DOI: https://dx.doi.org/10.4330/wjc.v12.i7.342